Automation runs amok

Volume and configuration challenges are leaving companies "dumbfounded" by EDI data forms, says a report on revenue leakage in biopharma distribution channels. Among other distribution inefficiencies: chargeback and return discrepancies, and concealed shortages. The damage? Eleven billion dollars per year, or about 4 percent of industry revenue. Article Perhaps sensing an opportunity, logistics solutions provider Accellos is acquiring vSync, a maker of EDI and shipping solutions for Microsoft Dynamics. Announcement

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)